In8bio
Latest round
- Series A
Last raised
- Jan 2019
Total raised
- $10M
Investors
- 1
About In8bio
Based in the US, In8bio, Inc.In8bio, Inc. specializes in innovative immunotherapy solutions, primarily utilizing gamma-delta T cells to target tumors. Founded in 2016, the company's headquarters is located in New York, US. The founders, Lawrence Lamb and William Ho, have extensive experience in the biopharmaceutical sector.25 mn.In8bio is dedicated to advancing gamma-delta T cell therapies specifically designed for the treatment of solid tumors and hematological cancers. Its primary investigational products include INB-400, which is in Phase 2 trials for newly diagnosed glioblastoma (GBM), and INB-200, currently undergoing Phase 1 trials targeting GBM. Additionally, INB-100 is in Phase 1 trials for leukemia patients receiving bone marrow transplants.In8bio's revenue model relies on strategic partnerships with clinical institutions and pharmaceutical companies to fund research and development initiatives.78 mn.25 mn, to advance its immunotherapy technology through both pre-clinical and clinical development programs. The company plans to enhance its product pipeline and expand into European markets alongside its existing North American presence. Upcoming product launches are anticipated to target new cancer therapies that leverage the DeltEx™ platform, further supporting In8bio's mission to provide effective treatment options for patients with cancer.
Who invested in In8bio
1 investor across 1 round
See all investors in In8bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 3, 2019
Amount
$10M
Investors
Questions about In8bio
Who invested in In8bio?
In8bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has In8bio raised?
In8bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did In8bio last raise money?
In8bio's most recent round on record is a Series A, in Jan 2019.
What does In8bio do?
In8bio is a biotechnology company.
Where is In8bio headquartered?
In8bio is headquartered in New York, US.
Which VCs invest in companies like In8bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at In8bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like In8bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.